Internal Medicine, Infectious Disease · Port Charlotte, FL
NPI
1497743744
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
21205 Olean Blvd, Suite A
Port Charlotte, FL, 33952
Phone (941) 613-2800
Groups this clinician bills Medicare through
Medicare paid, 2024
$416K
503,227 services
Medicare patients, 2024
643
Average age 77
Drug cost, 2024
$2.5M
2,214 prescriptions
Company payments, 2025
$780
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Karl G Damiani was code J0878 (injection, daptomycin, 1 mg), 431,470 times for 44 patients. In total Karl G Damiani billed 503,227 services in 44 codes, and Medicare paid $416K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0878 Injection, daptomycin, 1 mg | Office | 431,470 | 44 | $0.04 | $15K |
| J2248 Injection, micafungin sodium, 1 mg | Office | 40,100 | 16 | $0.41 | $16K |
| J2185 Injection, meropenem, 100 mg | Office | 4,120 | 20 | $0.30 | $1,235 |
| J0692 Injection, cefepime hydrochloride, 500 mg | Office | 4,004 | 57 | $1.00 | $3,987 |
| 96365 Intravenous Infusion, Hydration | Office | 3,632 | 145 | $46.69 | $170K |
| J7060 5% dextrose/water (500 ml = 1 unit) | Office | 2,842 | 76 | $1.41 | $3,993 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 2,321 | 108 | $0.51 | $1,187 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 1,452 | 17 | $0.34 | $494 |
| 96367 Intravenous Infusion, Hydration | Office | 1,269 | 49 | $21.25 | $27K |
| 99213 Office E&M - Established | Office | 873 | 248 | $67.38 | $59K |
| J1335 Injection, ertapenem sodium, 500 mg | Office | 710 | 27 | $9.27 | $6,579 |
| 96375 Injection Administration | Office | 407 | 11 | $11.60 | $4,721 |
| 99232 Hospital E&M - Subsequent | Facility | 392 | 234 | $61.06 | $24K |
| 36415 Venipuncture Blood Collection | Office | 334 | 114 | $8.52 | $2,846 |
| J3260 Injection, tobramycin sulfate, up to 80 mg | Office | 234 | 11 | $1.96 | $458 |
By year: 2022 $544K for 647,092 services; 2023 $594K for 997,504 services; 2024 $416K for 503,227 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 334 | 114 | $8.52 | $2,846 |
Medicare prescription drug claims, 2024
In 2024, the drug Karl G Damiani prescribed most often to Medicare patients was Azithromycin, with 287 prescriptions and refills. In total Karl G Damiani wrote 2,214 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azithromycin Generic | 287 | 665 | 72 | $6,147 |
| Cefdinir Generic | 161 | 257 | 82 | $3,725 |
| Methenamine Hippurate Generic | 145 | 305 | 46 | $11K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 123 | 139 | 15 | $560K |
| Ethambutol Hcl Generic | 88 | 181 | 27 | $6,364 |
| Cephalexin Generic | 79 | 181 | 32 | $3,257 |
| Doxycycline Hyclate Generic | 76 | 136 | 38 | $1,906 |
| Amikacin Sulfate Generic | 51 | 51 | Under 11 | $2,851 |
| Cefepime Hcl Generic | 50 | 50 | 12 | $9,405 |
| Vancomycin Hcl Generic | 48 | 61 | 25 | $9,457 |
| Prezcobix Darunavir/Cobicistat | 44 | 44 | Under 11 | $110K |
| Cefpodoxime Proxetil Generic | 43 | 85 | 20 | $3,886 |
| Efavirenz-Emtric-Tenofov Disop Efavirenz/Emtricit/Tenofovr Df | 43 | 43 | Under 11 | $25K |
| Triamcinolone Acetonide Generic | 42 | 44 | 23 | $534 |
| Mupirocin Generic | 34 | 37 | 13 | $309 |
Brand drugs: 448 claims; generic drugs: 1,766 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Karl G Damiani $780 ($780 in general payments such as food, travel and fees) from 8 companies. The largest payer was Insmed, Inc. with $213.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.